Objectives: Foetal hepatorenal toxicity and foetal morphology were evaluated following artemether administration to pregnant Wistar albino rats.
Introduction
Malaria is one of the commonest tropical diseases which is a major source of concern to the developing world in terms of morbidity and mortality in children and pregnant women, especially with the emergence of the resistance of the Plasmodium parasite [1] to common, affordable and readily available anti-malarial drugs. In 1998, about 373 million people were infected with malaria. In 2008, about 247 million cases of malaria were reported and nearly one million deaths were recorded annually among children living in Africa. [2] The World Malaria Report of 2014 showed that children under the age of 5 years are at high risk of malaria and they account for about 78% of deaths resulting from malaria. [1] Recent occurrence of malaria is estimated at 198 million (uncertainty range 124 million to 283 million) cases with estimated 367,000 to 755,000 deaths annually, 90% of them in Africa. [1] These statistics have shown a decrease in both the occurrence and mortality of malaria over the years, but the figures are still alarming and a cause for major concern.
Plasmodium falciparum is the most virulent of all Plasmodium species that cause malaria and is known to have the highest morbidity and mortality rate. [3] Malaria is transmitted from one infected person to another through a bite of an infected female Anopheles mosquito as vector. However, the intensity of transmission is dependent on factors related to the parasites, the vector, human host and the environment. Malaria is however a preventable and curable disease. Pregnant women are also very susceptible to malaria infection hence it constitutes a threat to both women and the foetuses.
Foetal hepatorenal toxicity and intrauterine growth retardation in pregnant Wistar rats treated with artemether
The prevalence of Plasmodium falciparum resistance to antimalarials especially in endemic regions further narrows the spectrum of antimalarial drugs available for use during pregnancy. The World Health Organization (WHO) has recommended the use of artemisinin-based combination therapy (ACT) for treatment of malaria in second and third trimesters of pregnancy. [2] Readily available, WHO-recommended ACTs include artemether-lumefantrine, artesunate-amodiaquine, artesunate-mefloquine, dihydroartemisinin-piperaquine and artesunate-sulfadoxinepyrimethamine. These drugs have been known to be very effective in the treatment and management of malaria, and several studies have been carried out to evaluate the effect of these therapies on the biological system. [4] [5] [6] [7] [8] Studies have focused on the effect of artemisinins during pregnancy in experimental animals. [9] The effect of artemether during different phases of pregnancy has been investigated in blastogenesis, organogenesis and foetal period. [10] At doses of 3.5 and 7 mg/kg/bw, artemether was observed to be lethal to embryos during organogenesis, and foetal growth retardation without incidence of malfunction was also observed. Furthermore, severe embryotoxicity has been reported for artemisinins, especially injectable artesunate at low doses in rodent, but embryotoxicity has not been convincingly observed in humans in clinical trials. [11] Embryo lethality and foetal cardiovascular as well as skeletal abnormalities have been observed for all derivatives of artemisinin at high doses. [12] Longo et al. [13] studied the effect of dihydroartemisinin on rat embryos and suggested that embryotoxicity of artemisinins may be due to oxidative stress induced by the drug.
Alpha-fetoprotein (AFP) is measured in pregnant women using maternal blood or amniotic fluid as a screening test for a subset of developmental abnormalities. AFP is particularly increased in open neural tube defect (NTD) and decreased in Down syndrome. It has also been used as a biomarker to detect tumours. [14] Foetal crown-rump length and body weight give an indication of foetal growth.
This study was designed to evaluate the foetal hepatorenal toxicity and intrauterine growth retardation following administration of artemether to pregnant Wistar albino rats.
Materials and Methods
Twenty pregnant female Wistar albino rats weighing between 180-200 g were used for the study. The rats were obtained from the animal house of the Department of Pharmacology, University of Calabar, Calabar, Nigeria and acclimatized for two weeks at the Animal House of Faculty of Basic Medical Sciences, University of Uyo, Nigeria. The approval for the study and the use of animals was obtained from the Faculty Animal Care and Use Committee of the Faculty of Basic Medical Sciences of University of Uyo, Uyo, Nigeria. Rules and regulations of Institute for Animal Ethical Committee (IAEC) were strictly followed and ethical standards from 1964 declaration of Helsinki were followed. The rats were fed with pellets and clean drinking water ad libitum. The rats were randomly divided into 4 groups of 5 per group. Female rats in proestrus phase of their cycle were transferred into a cage overnight with matured sexually active male Wistar albino rats. The vaginal aspirates were taken and smear done following overnight mating to demonstrate the presence of spermatozoa and this was taken to signify day zero of pregnancy. Group 1 served as control while Groups 2-4 received 1.1 mg, 2.2 mg, 3.3 mg of artemether per kilogram of body weight (bw) daily for five days between day 7 and day 11 of pregnancy.
Artemether manufactured by Greenlife Pharmaceuticals, Lagos, Nigeria was purchased from a registered pharmaceutical store in Uyo, Akwa Ibom State, Nigeria. Stock solution was prepared from the tablets and aliquots administered to the animals using cannula bypassing the oesophagus and delivered into the stomach based on the body weight.
The animals were sacrificed on the 20th day of the pregnancy under chloroform anaesthesia. The uterus was examined for the number of implantation sites, number of resorption sites and viable foetuses. The foetuses were delivered by uterotomy and examined for abnormal external features. Crown-rump length of each foetus was measured and the foetuses were weighed. The foetal liver and kidney were harvested and fixed in 10% formalin for histological studies using haemotoxylin and eosin techniques. Amniotic fluid was also collected for analysis of AFP using the alpha fetoprotein kits.
The preserved tissues were dehydrated with ascending grades of alcohol (70%, 90%, 95% and 100%) 1h/each concentration. The tissues were then cleared in two changes of xylene for one hour and then infiltrated with molten paraffin wax at 60°C two changes for an hour. The tissues were further embedded in molten paraffin and sectioned at 5 μm using a rotary microtome. The tissue sections were then stained using haemotoxylin and eosin. Light microscopic examinations were performed and presented as plates.
Statistical analysis was performed using analysis of variance (ANOVA) and Student's t-test. Experimental data were presented as mean ± standard deviation (SD). Values of p<0.05 were considered to be statistically significant.
Results

Effects of Artemether on the Morphology of Rat Foetuses and AFP
The mean crown-rump length (CRL) of the foetuses in the treated groups were 4.47 cm, 3.84 cm and 3.66 cm for Groups 2, 3 and 4, respectively. The means of Groups 3 and 4 showed a significant decrease when compared to control (4.74 cm) at p=0.05. The number of viable foetuses ranged between seven and ten which corresponded to the number of placental site noted. No dead foetuses and resorption sites were observed in any of the experimental groups. Significant reduction (P<0.05) was observed in rats in Groups 2, 3, and 4 compared to the control with respect to foetal body weight, CRL and AFP ( Table 1) . There was a dose-dependent reduction in the CRL of the foetuses.
Effects of Artemether on the Histology of the Liver of Rats Foetuses
Effects of artemether on the cytoarchitecture of the foetal liver of rats are shown in Figure 1 . The cytoarchitecture of liver of Group 1 was not altered. The cen- tral veins and the sinusoids were prominent while the hepatocytes were well outlined (Figure 1a) . The foetal liver from Group 2 animals (Figure 1b) treated with therapeutic dose (1.1 mg/kg) of artemether showed distorted architecture with marked inflammation. The central veins were dilated and congested. The sinusoids showed mononuclear infiltrate, and extensive hepatic necrosis was observed when compared to the control. There was an extensive hepatotropic necrosis with dilated sinusoidal spaces infiltrated with mononuclear inflammatory cells in the liver of Group 3 (Figure 1c) , while the liver of Group 4 showed distorted liver cytoarchitecture with extensive macrovesicular steatosis and hepatic necrosis with multinucleated cells (Figure 1d) .
Effects of Artemether on the Histology of the Kidney of Rat Foetuses
Effects of artemether on the cytoarchitecture of the foetal kidney of rats are shown in Figure 2 . The foetal kidney of Group 1 (Figure 2a) showed distinct cortical medullary region, while moderate degeneration of glomeruli and narrowing of the capsular space were observed in Group 2 (Figure 2b) . The foetal kidney of Group 3 showed disorganised renal structural details, atrophic and degenerated glomeruli with acute tubular necrosis (Figure 2c) . Severe degenerated glomeruli with periarterioler haemorrhages and acute tubular necrosis were observed in foetal kidney of Group 4 (Figure 2d ).
Discussion
In this study, foetal body weight and CRL were used to evaluate foetal growth morphology. The result revealed a reduction in the weight and CRL of the foetuses following administration of artemether. This is suggestive of intrauterine growth retardation. Similar observation was also made when artesunate was administered to pregnant Wistar rats in order to study its effect on the morphometry of foetal central nervous system. [15] Observations on the foetal weight and CRL of Wistar albino rats have been reported following the administration of artesunate, artemether and arteether, [9] Aloe vera, [16] or pyrimethamine. [17] Ekanem et al. [18] also reported that pyrimethamine had a deleterious effect on the foetal epiphysis leading to growth retardation and developmental anomalies.
AFP is measured in pregnant women using maternal blood or amniotic fluid as a screening test for a subset of developmental abnormalities. It is particularly increased in open neural tube defect and decreased in Down syndrome. It has also been used as a biomarker to detect tumours. [14] There has been a correlation between amniotic fluid AFP and occurrence of neural tube defects. [19] The AFP in this study was significantly reduced in treatment groups compared to the control, implying that there was no gross foetal malformation except histologically, the liver which is another source of AFP had been significantly affected in the treated groups. This findings support the study by Bhabagrahi et al. [9] which reported that artemisinin has significant embryo-foetal toxicity in rats without any gross malformation. Elevation of AFP has been reported to result from the leakage of foetal serum through a disrupted and necrotic nervous tissues into the amniotic fluid. [20] Most drugs are metabolised and eliminated in the liver and kidney, but the liver is more susceptible to drug toxicity. [21] Teratogenic effects of drugs have been well documented. [19] Hepatocyte necrosis, hepatitis, cholestasis and fibrosis are common manifestations of liver toxicity. In this study, we observed derangements and degenerations in the foetal liver of the rats with increasing doses of artemether compared to the control. Cellular damage and a progressive cytoarchitectural damage of the foetal liver were observed in the treated animals. Congested and dilated sinusoids and central veins, hepatocytic necrosis and microvesicular steotosis were observed. Toxicological study of Ginkgo biloba in mice foetus by Zehra et al. [22] also reported similar findings.
The kidney filters and removes toxic substances from the body. Certain drugs have been found to be nephrotoxic. Mild to severe alteration in the histology of the foetal kidney was observed in this study following the administration of artemether. The degeneration of renal glomeruli and the disorganisation of the renal structural details in this study were similar to other studies where teratogenic nephrotoxicity of Aloe vera, [16] beer and palm wine [23] were reported.
Conclusion
The results of this study showed that artemether crosses the uteroplacental barrier to cause intrauterine growth retardation or stunted growth, as well as foetal hepatotoxicity and nephrotoxicity in Wistar albino rats.
